Regular Review
Surgery for pancreatic cancer DAVID C CARTER Pancreatic cancer presents an increasing diagnostic and therapeutic challenge. Over the past 40 years its incidence appears to have trebled in the United States' and doubled in England and Wales.2 About 10 new cases now develop per 100 000 population per year in most Western societies, and pancreatic cancer now ranks fifth and sixth in men and women respectively in the United States as a cause of death from cancer. 3 Despite the accuracy of new diagnostic techniques such as ultrasound, endoscopic retrograde cholangiopancreatography (ERCP), CT scanning, percutaneous transhepatic cholangiography, and angiography, diagnosis is usually still delayed until the disease has spread beyond the reach of surgical resection. The identification of "tumour markers" such as pancreatic oncofetal antigen4 5 offers promise for population screening and early diagnosis, but this promise remains far from clinical application.
At present, radical surgery offers the only prospect of cure, and the prognosis remains appalling. Most patients are dead within six months of diagnosis, some 900% are dead within a year, and survival beyond five years is exceptional-a gloomy background against which to review current surgical attitudes to the disease. Limitations of surgical statistics-Surgeons have been reluctant to biopsy the pancreas, and inspection and palpation of the gland at laparotomy are notoriously inaccurate, leading to diagnostic error in as many as 2500 of cases. cumulative survival rates showed no significant differences between the two groups, and to date there have been no fiveyear survivors.
On the basis of his own data and those of six similar retrospective reports, Shapiro20 concluded that patients with disease apparently limited to the pancreas treated by Whipple resection fared no better than those treated by bypass. Nevertheless, after a review of reports of 496 patients treated by Whipple resection, he pointed out that the 20 five-year survivors might have been denied their apparent cure had they merely undergone bypass surgery. Occasionally, however, patients survive five years after bypass.7 Furthermore, the mean operative mortality of Whipple resection in these patients was 21%. As they were "good risk" patients, many of the 103 who died in the postoperative period might have been expected to survive for some six to 12 months had bypass been undertaken.
It is, indeed, the high operative mortality of Whipple resection that is crucial in any assessment of its place in treating pancreatic cancer. Much of the problem stems from the high complication rate which attends drainage of the pancreatic remnant into a loop of jejunum. Lower complication and mortality rates may possibly be achieved in specialist units; certainly Whipple resection should not be attempted by inexperienced surgeons. When a potentially resectable pancreatic cancer is found at laparotomy in a patient with obstructive jaundice the best course of action is insertion of a T tube high in the common bile duct and referral to a specialist centre.
Even in the best hands the mortality will remain high, however; and many surgeons believe that Whipple resection should be abandoned for pancreatic cancer, and that they should practise palliative bypass surgery or opt for some safer form ofresection.
Whipple operation or total pancreatectomy ?-Total pancreatectomy removes the risk of postoperative pancreatitis and eliminates the need for pancreaticojejunal anastomosis and its attendant hazards, at the expense of removing all endocrine and exocrine pancreatic function. The operation of total pancreatectomy is not new, but the unsatisfactory results of the Whipple operation have prompted its reappraisal.
Comparison of the two operations is hampered by a lack of controlled data. It is made even more difficult by the inclusion of patients without cancer or those with cancer of the duodenum, ampullary region, or distal common bile duct. Pliam and ReMine23 reported an operative mortality for total pancreatectomy of 21% in 1942-68, falling to 12.5% in 1969-73, and to 7-4% if only those operations performed since 1970 were considered. Nevertheless, the subgroup of patients undergoing total pancreatectomy for pancreatic cancer in 1969-73 had an operative mortality rate of 23% Ihse and colleagues24 reported a hospital mortality of 23% in 65 patients undergoing total pancreatectomy over a 17-year period, 58 of whom had cancer of the pancreas. Even so, their mortality had fallen in recent years to 17% and was only 12%
(six out of 48) when the operation was undertaken by senior surgeons trained in pancreatic surgery.
Overall, the mortality reported9 [23] [24] [25] for total pancreatectomy for pancreatic cancer seems no better than that of Whipple resection-roughly 20%. Possibly improved standards and techniques will reduce these rates to more acceptable levels, and many surgeons argue that the mortality after total pancreatectomy at least should not exceed that of Whipple resection.
Forrest and Longmire9 performed Whipple resection in 51 patients, all but one of whom had adenocarcinoma of the pancreas. On completion of the operation only 39 were thought to have had clearance of all obvious deposits of tumour, but after pathological examination of the resected specimen only 31 of these had resection lines clear of tumour. Survival rates were better in patients with clear resection lines, and patients undergoing "palliative" Whipple operations fared no better than those having bypass surgery. Forrest Comparison of long-term survival after the various forms of pancreatic resection is impossible in the absence ofcontrolled data. The root problem remains one of late diagnosis rather than extent of resection, and any improvement in five-year survival rates from widespread application of total pancreatectomy seems destined to be marginal.
Diabetes is inevitable after total pancreatectomy. Advocates of total pancreatectomy point out that some 16%, to 38% of patients with pancreatic cancer are diabetic preoperatively,9 23 and that diabetes is not uncommon after Whipple resection.24 25 Patients who have had a total pancreatectomy are very sensitive to insulin, and half of them will have hypoglycaemic episodes while in hospital after operation.22 Postpancreatectomy diabetes is, however, rarely difficult to manage.9 23 25 Once the patient has recovered from the immediate effects of surgery, however, both patient and general practitioner must be made aware of the potential danger of insulin sensitivity, and the ease with which fatal hypoglycaemia may be induced. Exocrine insufficiency remains a major problem after both partial and total pancreatectomy, and steatorrhoea is the main disadvantage of pancreatic resection. In theory, worthwhile exocrine pancreatic function should be retained after Whipple resection, but the clinical results are often disappointing. Forrest and Longmire9 believe that the pancreatic ducts and pancreaticojejunal anastomosis may stenose after a variable interval. Examination of pancreatic resection specimens shows fibrosis and degeneration in the body and tail of the gland by the time of surgery in almost half of patients with carcinoma of the head of pancreas. 24 Individual susceptibility to steatorrhoea varies greatly after total pancreatectomy. Oral pancreatic supplements should be prescribed routinely, and most patients eventually pass two to three stools a day after a much more frequent bowel habit in the early postoperative period. Nevertheless, steatorrhoea may prove incapacitating in some patients despite increased intake of enzyme preparations. Non-specific drugs may be useful for slowing intestinal transit in such individuals.
The loss of pancreatic bicarbonate secretion after pancreatectomy predisposes to peptic ulceration, and partial gastrectomy or truncal vagotomy with antrectomy are now essential extensions of pancreaticoduodenal resection. Further reduction in the secretion of acid and pepsin by histamine H2-receptor antagonists or antacids may be useful in patients with persistent troublesome steatorrhoea. 27 The loss of endogenous pancreatic exocrine secretion is reflected in restriction of physical activity and failure to regain weight after operation. Patients rarely regain their ideal weight after pancreatectomy, but progressive loss of weight is often an indication of progression of malignant disease.
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